Conducting Pharmaceutical Inspections in the Russian Federation to Ensure Compliance with the EAEU GCP Requirements Is an Accepted Necessity
Inspections of pharmaceutical market participants to verify their compliance with good practice requirements are integral to good regulatory practices of the Member States of the Eurasian Economic Union (EAEU). The framework for Good Clinical Practice (GCP) inspections is outlined in Decision No. 78...
Main Author: | A. A. Trapkova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2023-06-01
|
Series: | Безопасность и риск фармакотерапии |
Subjects: | |
Online Access: | https://www.risksafety.ru/jour/article/view/370 |
Similar Items
-
Risk Management Plan: An Expert Analysis of Changes to the EAEU Good Pharmacovigilance Practice Requirements for the Content and Submission of the Document
by: T. M. Bukatina, et al.
Published: (2023-03-01) -
Pharmaceutical Market of the EAEU: Trends and Prospects of Development
by: A. A. Vorona, et al.
Published: (2022-12-01) -
Pharmacovigilance System Master File: An Overview of Changes in the EAEU Good Pharmacovigilance Practice
by: N. Yu. Velts, et al.
Published: (2023-03-01) -
Analysis of the provisions of national and EAEU legislation regulating pharmaceuticals before and after 1 January 2026
by: A. G. Zaremba, et al.
Published: (2023-12-01) -
Participants’ awareness of ethical compliance, safety and protection during participation in pharmaceutical industry clinical trials: a controlled survey
by: Gerardo González-Saldivar, et al.
Published: (2019-01-01)